Conference Coverage

VIDEO: Unraveling Alzheimer’s pathogenesis while testing lifestyle interventions


 

EXPERT ANALYSIS FROM THE ADRD SUMMIT 2016

References

BETHESDA, MD. – Alzheimer’s disease is not the failure of a single type of cell – or even a single physiologic system, so while the search for effective treatments goes on, basic research must continue to unravel many of its fundamental mechanisms, according to Dr. Ronald Petersen, director of the Mayo Clinic Alzheimer’s Disease Research Center in Rochester, Minn.

But in lieu of available treatments that target the underlying pathology of Alzheimer’s, trials must continue to test lifestyle interventions with diet and exercise that in preliminary studies have started proving their worth in decreasing the risk of cognitive decline or delaying its onset.

Dr. Petersen discussed these issues in an interview at the Alzheimer’s Disease–Related Dementias 2016 Summit, sponsored by the National Institutes of Health.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

msullivan@frontlinemedcom.com

On Twitter @alz_gal

Recommended Reading

VIDEO: How to navigate value-based care payer contracts
MDedge Family Medicine
VIDEO: Treat most older women with stage I breast cancer with lumpectomy only
MDedge Family Medicine
Antidepressants tied to lower dementia mortality
MDedge Family Medicine
Reslizumab especially effective in eosinophilic asthma with nasal polyps
MDedge Family Medicine
Drug interaction myths
MDedge Family Medicine
Higher levels of function before hip fracture tied to greater fears of falling at 1 year
MDedge Family Medicine
Heart attack patients getting younger, fatter, and less healthy
MDedge Family Medicine
Prepsychosis links with elevated metabolic syndrome
MDedge Family Medicine
Losmapimod failed to beat placebo in acute MI trial
MDedge Family Medicine
VIDEO: New ACC consensus guidance addresses nonstatin therapies
MDedge Family Medicine